SNRK (SNF1-related kinase), a serine/threonine kinase first identified from the earliest population of CD34+ hematopoietic progenitors that form in the aorta of the human embryo, has been scarcely reported regarding its role in breast cancer and TANs 38. The gene discussed is MARK2; the disease is breast carcinoma.